Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation
Journal of Experimental Medicine · 03.04.2023 · 220 (4)
DOI: 10.1084/jem.20220741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 23.01.2023. Verfasst von Milena Petkova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala, Sweden. Hauptthemen laut MEDLINE: Endothelial Cells, Lymphatic Vessels. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swedish Research Council, Knut and Alice Wallenberg Foundation.
Abstract (Originalsprache)
Oncogenic mutations in PIK3CA, encoding p110α-PI3K, are a common cause of venous and lymphatic malformations. Vessel type–specific disease pathogenesis is poorly understood, hampering development of efficient therapies. Here, we reveal a new immune-interacting subtype of Ptx3-positive dermal lymphatic capillary endothelial cells (iLECs) that recruit pro-lymphangiogenic macrophages to promote progressive lymphatic overgrowth. Mouse model of Pik3caH1047R-driven vascular malformations showed that proliferation was induced in both venous and lymphatic ECs but sustained selectively in LECs of advanced lesions. Single-cell transcriptomics identified the iLEC population, residing at lymphatic capillary terminals of normal vasculature, that was expanded in Pik3caH1047R mice. Expression of pro-inflammatory genes, including monocyte/macrophage chemokine Ccl2, in Pik3caH1047R-iLECs was associated with recruitment of VEGF-C–producing macrophages. Macrophage depletion, CCL2 blockade, or anti-inflammatory COX-2 inhibition limited Pik3caH1047R-driven lymphangiogenesis. Thus, targeting the paracrine crosstalk involving iLECs and macrophages provides a new therapeutic opportunity for lymphatic malformations. Identification of iLECs further indicates that peripheral lymphatic vessels not only respond to but also actively orchestrate inflammatory processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet , Campus Flemingsberg, Neo, Huddinge, Sweden.
- Department of Dermatology, Hospital Sant Joan de Déu , Esplugues de Llobregat, Spain.
- Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC) , Badalona, Spain.
- CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
- ICREA, Barcelona, Spain.
ORCID-Profile: Milena Petkova, Marle Kraft, Simon Stritt, Ines Martinez-Corral, Henrik Ortsäter, Michael Vanlandewijck, Bojana Jakic, Eulàlia Baselga, Sandra D Castillo, Mariona Graupera, Christer Betsholtz, Taija Mäkinen
Förderung
- European Research Council
- Swedish Research Council
- Knut and Alice Wallenberg Foundation
- Göran Gustafsson Stiftelser
- Swedish Cancer Society
- H2020 Marie Skłodowska-Curie Actions
- La Caixa Foundation
- La Caixa Banking Foundation
Zitieren
APA
Petkova, M., Kraft, M., Stritt, S., Martinez-Corral, I., Ortsäter, H., Vanlandewijck, M., Jakic, B., Baselga, E., Castillo, S. D., Graupera, M., Betsholtz, C., & Mäkinen, T. (2023). Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation. Journal of Experimental Medicine, 220(4). https://doi.org/10.1084/jem.20220741
Vancouver
Petkova M, Kraft M, Stritt S, Martinez-Corral I, Ortsäter H, Vanlandewijck M, et al. Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation. Journal of Experimental Medicine. 2023;220(4). doi:10.1084/jem.20220741
BibTeX
@article{Petkova2023,
author = {Petkova, Milena and Kraft, Marle and Stritt, Simon and Martinez-Corral, Ines and Ortsäter, Henrik and Vanlandewijck, Michael and Jakic, Bojana and Baselga, Eulàlia and Castillo, Sandra D and Graupera, Mariona and Betsholtz, Christer and Mäkinen, Taija},
title = {Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation},
journal = {Journal of Experimental Medicine},
year = {2023},
volume = {220},
number = {4},
doi = {10.1084/jem.20220741}
}
EUVIMED